Variables | PAL rate (%) | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | ||
Age | 15.6 | 1.029 | 1.016–1.043 | < 0.001 | 1.020 | 1.004–1.037 | 0.013 |
Gender | Â | Â | Â | < 0.001 | Â | Â | 0.819 |
 Female | 12.7 | Ref. |  |  | Ref. |  |  |
 Male | 19.6 | 1.665 | 1.276–2.174 |  | 0.951 | 0.619–1.462 |  |
BMI | 15.6 | 0.914 | 0.875–0.955 | < 0.001 | 0.884 | 0.842–0.928 | < 0.001 |
Smoking history | Â | Â | Â | < 0.001 | Â | Â | 0.030 |
 Non-smoker | 12.5 | Ref. |  |  | Ref. |  |  |
 Smoker | 24.3 | 2.239 | 1.697–2.955 |  | 1.628 | 1.048–2.531 |  |
Hypertension | Â | Â | Â | 0.299 | Â | Â | Â |
 No | 15.0 | Ref. |  |  |  |  |  |
 Yes | 17.1 | 1.166 | 0.872–1.559 |  |  |  |  |
Diabetes mellitus | Â | Â | Â | 0.996 | Â | Â | Â |
 No | 15.6 | Ref. |  |  |  |  |  |
 Yes | 15.6 | 0.996 | 0.676–1.467 |  |  |  |  |
COPD | Â | Â | Â | 0.022 | Â | Â | 0.080 |
 No | 15.4 | Ref. |  |  | Ref. |  |  |
 Yes | 37.5 | 3.299 | 1.188–9.157 |  | 2.836 | 0.883–9.107 |  |
Neoadjuvant therapy | Â | Â | Â | 0.063 | Â | Â | 0.753 |
 No | 15.4 | Ref. |  |  | Ref. |  |  |
 Yes | 28.6 | 2.201 | 0.959–5.052 |  | 0.862 | 0.343–2.165 |  |
History of thoracic surgery | Â | Â | Â | 0.404 | Â | Â | Â |
 No | 15.7 | Ref. |  |  |  |  |  |
 Yes | 9.1 | 0.537 | 0.125–2.313 |  |  |  |  |
FEV1 % predicted | 15.6 | 0.983 | 0.976–0.991 | < 0.001 | 0.991 | 0.981–1.000 | 0.046 |
MVV% predicted | 15.6 | 0.989 | 0.983–0.996 | 0.002 | 0.999 | 0.994–1.004 | 0.639 |
Blood type | Â | Â | Â | 0.195 | Â | Â | 0.166 |
 A | 17.3 | Ref. |  |  | Ref. |  |  |
 B | 15.2 | 0.857 | 0.617–1.189 |  | 0.877 | 0.618–1.244 |  |
 AB | 10.3 | 0.548 | 0.315–0.955 |  | 0.509 | 0.282–0.919 |  |
 O | 16.2 | 0.923 | 0.652–1.306 |  | 0.912 | 0.627–1.326 |  |
Lymphocyte | 15.6 | 0.804 | 0.631–1.023 | 0.076 | 0.902 | 0.697–1.168 | 0.433 |
Albumin | 15.6 | 1.015 | 0.986–1.046 | 0.313 |  |  |  |
PNI | 15.6 | 0.999 | 0.975–1.024 | 0.955 |  |  |  |
ASA score | Â | Â | Â | 0.007 | Â | Â | 0.264 |
 I | 11.7 | Ref. |  |  | Ref. |  |  |
 II | 15.5 | 1.385 | 0.841–2.282 |  | 0.879 | 0.497–1.555 |  |
 III | 31.8 | 3.512 | 1.587–7.775 |  | 1.590 | 0.622–4.063 |  |
Surgical technique | Â | Â | Â | 0.316 | Â | Â | Â |
 RATS | 16.9 | Ref. |  |  |  |  |  |
 VATS | 15.0 | 0.867 | 0.657–1.145 |  |  |  |  |
Surgical procedure | Â | Â | Â | < 0.001 | Â | Â | < 0.001 |
 Sublobar resection | 8.7 | Ref. |  |  | Ref. |  |  |
 Lobectomy | 21.7 | 2.903 | 2.159–3.902 |  | 2.100 | 1.424–3.096 |  |
Surgical range | Â | Â | Â | 0.001 | Â | Â | 0.002 |
 Mono-lobe | 14.4 | Ref. |  |  | Ref. |  |  |
 Multi-lobe | 22.9 | 1.764 | 1.258–2.473 |  | 1.820 | 1.251–2.648 |  |
Operation side | Â | Â | Â | 0.141 | Â | Â | 0.035 |
 Left-sided | 17.2 | Ref. |  |  | Ref. |  |  |
 Right-sided | 14.5 | 0.818 | 0.625–1.069 |  | 0.730 | 0.545–0.977 |  |
Operation duration | 15.6 | 1.012 | 1.009–1.016 | < 0.001 | 1.009 | 1.005–1.012 | < 0.001 |
Number of LN dissected | 15.6 | 1.076 | 1.051–1.102 | < 0.001 | 1.019 | 0.989–1.050 | 0.224 |
Tumor size | 15.6 | 1.340 | 1.210–1.484 | < 0.001 | 1.038 | 0.921–1.171 | 0.539 |